(Q45789678)

English

High-performance liquid chromatography and photoaffinity crosslinking to explore the binding environment of nevirapine to reverse transcriptase of human immunodeficiency virus type-1

scientific article published on July 29, 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7522840

High-performance liquid chromatography and photoaffinity crosslinking to explore the binding environment of nevirapine to reverse transcriptase of human immunodeficiency virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7522840

High-performance liquid chromatography and photoaffinity crosslinking to explore the binding environment of nevirapine to reverse transcriptase of human immunodeficiency virus type-1 (English)

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

1 reference

based on heuristic

inferred from title

affinity labels

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522840

16 May 2024

author name string

D. E. Palladino

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522840

16 May 2024

J. L. Hopkins

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522840

16 May 2024

R. H. Ingraham

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522840

16 May 2024

T. C. Warren

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522840

16 May 2024

S. R. Kapadia

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522840

16 May 2024

G. J. Van Moffaert

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522840

16 May 2024

P. M. Grob

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522840

16 May 2024

J. M. Stevenson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522840

16 May 2024

K. A. Cohen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522840

16 May 2024

language of work or name

0 references

publication date

1 July 1994

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7522840

29 July 1994

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7522840

16 May 2024

full work available at URL

https://api.elsevier.com/content/article/PII:0021967394804583?httpAccept=text/xml

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

https://api.elsevier.com/content/article/PII:0021967394804583?httpAccept=text/plain

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Journal of Chromatography

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7522840

676

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7522840

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7522840

99-112

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7522840

A detailed model of reverse transcription and tests of crucial aspects

1

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

2

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

3

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study

4

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Mechanism of HIV reverse transcriptase: enzyme-primer interaction as revealed through studies of a dNTP analogue, 3'-azido-dTTP.

5

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

7

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Mitochondrial myopathy caused by long-term zidovudine therapy

8

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

9

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

10

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

11

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase

12

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

14

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug

15

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.

16

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus.

17

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site

18

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors

20

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors

21

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

22

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Another piece of the HIV puzzle falls into place

23

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Comparative purification of recombinant HIV-1 and HIV-2 reverse transcriptase: Preparation of heterodimeric enzyme devoid of unprocessed gene product

24

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones

25

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinones

26

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

High-performance liquid chromatographic peptide mapping and amino acid analysis in the sub-nanomole range

27

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

37 Strategies and reagents for photoaffinity labeling of mechanochemical proteins

28

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Reversed-phase high-performance liquid chromatography for fractionation of enzymatic digests and chemical cleavage products of proteins

30

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Identification of an active site peptide of skeletal myosin after photoaffinity labeling with N-(4-azido-2-nitrophenyl)-2-aminoethyl diphosphate

32

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Identification and amino acid sequence of the deoxynucleoside triphosphate binding site in Escherichia coli DNA polymerase I.

33

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Pyridoxal 5'-phosphate mediated inactivation of Escherichia coli DNA polymerase I: identification of lysine-635 as an essential residue for the processive mode of DNA synthesis

35

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Affinity labeling of hemoglobin with 4,4'-diisothiocyanostilbene-2,2'-disulfonate: covalent cross-linking in the 2,3-diphosphoglycerate binding site

36

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Serine-324 of myosin's heavy chain is photoaffinity-labeled by 3'(2')-O-(4-benzoylbenzoyl)adenosine triphosphate

37

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Lysine-329 of murine leukemia virus reverse transcriptase: possible involvement in the template-primer binding function

39

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Active-site mapping and site-specific mutagenesis of glycinamide ribonucleotide transformylase from Escherichia coli

40

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Ferrate oxidation of murine leukemia virus reverse transcriptase: identification of the template-primer binding domain

42

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Photoaffinity labeling of the primer binding domain in murine leukemia virus reverse transcriptase

43

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Identification of the primer binding domain in human immunodeficiency virus reverse transcriptase

44

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Identification of peptides from the adenine binding domains of ATP and AMP in adenylate kinase: isolation of photoaffinity-labeled peptides by metal chelate chromatography

45

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Active site studies of human immunodeficiency virus reverse transcriptase

46

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins

47

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Use of scanning diode array detector with reversed-phase microbore columns for the real-time spectral analysis of aromatic amino acids in peptides and proteins at the subsmicrogram level

48

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

HIV reverse transcriptase structure-function relationships

51

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA

52

1 reference

10.1016/0021-9673(94)80458-3

https://api.crossref.org/works/10.1016/0021-9673(94)80458-3

16 May 2024

Identifiers

10.1016/0021-9673(94)80458-3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7522840

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7522840

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45789678&oldid=2155576015"